skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

63 studies were found about Prevention Research, Microbicides

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

Condition: HIV Infections

NCT ID: NCT00594373

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

Condition: HIV Infections

NCT ID: NCT00441298

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

Condition: HIV Infections

NCT ID: NCT00408538

Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00441909

A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel

Condition: HIV Infections

NCT ID: NCT00304642

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium

Condition: HIV Infections; HIV-1

NCT ID: NCT00309205

Safety and Acceptability of a Vaginal Microbicide

Condition: HIV Infections; Hepatitis B, Chronic

NCT ID: NCT00111943

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

Condition: HIV Prevention; HIV Infections

NCT ID: NCT00984971

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa

Condition: HIV Infections

NCT ID: NCT00304668

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

Condition: HIV Infections

NCT ID: NCT00074425

A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel

Condition: HIV Infections

NCT ID: NCT00303576

Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery

Condition: HIV Infections

NCT ID: NCT00540605

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

Condition: HIV Infections

NCT ID: NCT00592124

Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women

Condition: HIV Infections

NCT ID: NCT00705679

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

Condition: HIV Infections

NCT ID: NCT00561496

Botswana Study of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00385554

Safety Study of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00446979

Study of UC-781 Vaginal Microbicide

Condition: HIV Infections

NCT ID: NCT00132444

Microbicides Acceptability Among Sexually Active Young Women

Condition: HIV Infections

NCT ID: NCT00490152

Safety of Acidform Lubricant in HIV-Uninfected Women

Condition: HIV Infections

NCT ID: NCT00850837

Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India

Condition: HIV Infections

NCT ID: NCT00081640

Microbicide Safety and Acceptability in Young Men

Condition: High Risk MSM; HIV Negative; 18-30 Years of Age

NCT ID: NCT01283360

Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission

Condition: HIV Infections; AIDS; Sexually Transmitted Diseases; HIV Seroconversion

NCT ID: NCT00213083

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

Condition: HIV Infections

NCT ID: NCT00028132

Tenofovir Gel in Pregnancy and Lactation

Condition: HIV Infections

NCT ID: NCT01136759

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Healthy

NCT ID: NCT00917904

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00917891

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

Condition: HIV Prevention

NCT ID: NCT01575405

Cellulose Sulfate (CS) Gel and HIV in Nigeria

Condition: HIV Infections; Gonorrhea; Chlamydia Infections

NCT ID: NCT00120770

An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations

Condition: HIV Prevention

NCT ID: NCT01575418

A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States

Condition: HIV-1 Infections

NCT ID: NCT00799058

Safety and Acceptability of Carraguard™ Among HIV-Negative Couples in Thailand

Condition: HIV Infections; Chlamydia Trachomatis; Nesseria Gonorrhea; Trichomonas Vaginitis; Syphilis

NCT ID: NCT00213057

Safety and Tolerability of the Vaginal Gel PRO 2000/5

Condition: HIV Infections

NCT ID: NCT00006207

Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women

Condition: HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00136643

Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use

Condition: HIV

NCT ID: NCT02033109

SPL7013 Gel - Male Tolerance Study

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT00370357

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

Condition: HIV Infections

NCT ID: NCT00729573

Effects of BufferGel and PRO 2000/5 Gel in Men

Condition: HIV Infections

NCT ID: NCT00016536

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Condition: HIV

NCT ID: NCT01691768

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

Condition: HIV Prevention

NCT ID: NCT01768962

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Condition: HIV Infections

NCT ID: NCT00214812

A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides

Condition: HIV Infections

NCT ID: NCT00389311

HIV Prevention Preparedness Study

Condition: HIV Infections; HIV Seronegativity

NCT ID: NCT00048282

Biomarkers of Protocol Compliance and Product Adherence

Condition: HIV Prevention

NCT ID: NCT01804023

Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation

Condition: HIV Infections

NCT ID: NCT00872261

Safety and Acceptability of Carraguard® in HIV Positive Women and Men

Condition: HIV Infections

NCT ID: NCT00213005

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

Condition: HIV Infections

NCT ID: NCT00613249

A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium

Condition: HIV Infections

NCT ID: NCT01242579

Assessing the Safety of Dapivirine Gel and Film Formulations

Condition: HIV Infections

NCT ID: NCT01548560

62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides

Condition: Sexually Transmitted Infections

NCT ID: NCT00469547

A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00213044

Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures

Condition: Topical Penile Exposures

NCT ID: NCT01277640

Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

Condition: HIV Infections

NCT ID: NCT01490671

Reactogenicity and Immunogenicity of Vaginal CNgp140

Condition: HIV Infections; Acquired Immune Deficiency Syndrome

NCT ID: NCT00637962

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

Condition: HIV

NCT ID: NCT01989663

Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

Condition: HIV

NCT ID: NCT01687218

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

Condition: HIV Prevention

NCT ID: NCT01813162

Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use

Condition: HIV Prevention

NCT ID: NCT01421368

A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients

Condition: HIV

NCT ID: NCT01946009

Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi

Condition: Bacterial Vaginosis; Trichomonas Vaginitis; Urogenital Diseases

NCT ID: NCT00140764

Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus

Condition: Anal Cancer; Precancerous Condition

NCT ID: NCT00550589

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Condition: Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment

NCT ID: NCT01259219

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel

Condition: Prevention

NCT ID: NCT01369303